IMVT: Immunovant, Inc. O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
IgG kamaytirish bo'yicha noyob patentlar raqobatchilar uchun kuchli to'siqni yaratadi va GURU.Markets platformasidagi joriy PEG koeffitsiyentining ushbu chiziqli grafigi Immunovant, Inc. (IMVT) aktivining salohiyatini aniq tasdiqlaydi. 0.00 ushbu metrika uchun joriy marker vazifasini o'taydi. Immunovant, Inc. (IMVT) FcRn ingibitorlari orqali immunologiya sohasida global yetakchilikka intilmoqda, autoimmun patologiyalarni davolashga bo'lgan barqaror talab esa iqtisodiy sikllarning ta'sirini yumshatadi.
Immunovant, Inc. (IMVT) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Immunovant, Inc.|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi immunovant.com|IMVT - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Immunovant Corp|IMVT - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Immunovant|Tezkor likvidlik ko‘rsatkichi immunovant.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
IMVT - Kompaniyaning sof foydasi|Kelajakdagi foyda Immunovant, Inc.|IMVT - Narx-foyda koeffitsiyenti|Forvard P/E multiplikatori Immunovant Therapeutics|IMVT - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Immunovant Corp|IMVT - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Immunovant|IMVT - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi immunovant.com|IMVT - Joriy yilda foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Immunovant, Inc.
Kompaniyaning umumiy tahlili:IMVT - Immunovant Inc
Immunovant, Inc. (IMVT) tashqi sotib olishlarsiz o'zining asosiy molekulasi ustidagi organik tadqiqotlarga e'tibor qaratishi kompaniyani ichki ishlanmalar samaradorligiga bog'liq qiladi. PEG koeffitsiyentini tahlil qilish orqali investor joriy aksiya narxini foyda o'sishi sur'ati bilan bog'laydi: birdan past qiymat biznesning o'sish potentsialiga nisbatan fundamental past baholanganligidan dalolat beradi.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Kiniksa (KNSA) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Grifols SA|Narx-foyda va o‘sish multiplikatori ADPT|PEG multiplikatori Celldex Corp|Narxning foydaga va o‘sish sur’atiga nisbati Aurinia Pharmaceuticals (AUPH)|biocryst.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori VERA (Vera Therapeutics)|Dianthus Therapeutics Inc (DNTH) - O‘sish sur’atiga tuzatilgan narx-foyda|Pharvaris Corp - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati AbCellera Biologics ABCL|Tourmaline Bio, Inc. (TRML) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori precigen.com|Narxning foydaga va o‘sish sur’atiga nisbati Pharming Group|Narx-foyda va o‘sish multiplikatori Nektar Therapeutics Inc (NKTR)|Narx-foyda va o‘sish multiplikatori UPB (Upstream Bio Corp)|PEG multiplikatori Zenas Corp (ZBIO)|Narxning foydaga va o‘sish sur’atiga nisbati Immunome, Inc. IMNM|GOSS: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|KALV - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Septerna, Inc.|PVLA (Pieris Pharmaceuticals Inc) - Narx-foyda va o‘sish multiplikatori|SVRA (Savara Pharma) - Narxning foydaga va o‘sish sur’atiga nisbati|RIGL (Rigel Pharmaceuticals) - PEG multiplikatori|PEG multiplikatori anaptysbio.com|Narxning foydaga va o‘sish sur’atiga nisbati Astria Therapeutics, Inc. (ATXS)|enGene Holdings Inc - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|RAPT Therapeutics, Inc. - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati JBIO (Aerovate Therapeutics, Inc.)|ACRS: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti KYTX (kyvernatx.com)|TLSA: PEG multiplikatori|CABA - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Ventyx Bio|O‘sishni hisobga olgan narx-foyda koeffitsiyenti THTX (Theratechnologies, Inc)|PEG multiplikatori AVTX|Narx-foyda va o‘sish multiplikatori eledon.com ELDN|Agenus Inc. - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Climb Bio Inc. (CLYM)|Zura Bio Limited - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati aTyr Pharmaceuticals ATYR|adagene.com (ADAG) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Ikena Oncology|Narx-foyda va o‘sish multiplikatori STTK|Narxning foydaga va o‘sish sur’atiga nisbati EQ|Narx-foyda va o‘sish multiplikatori CNTB (Connect Biopharma)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati IMUX|Narxning foydaga va o‘sish sur’atiga nisbati Atara Bio ATRA|IFRX (InflaRx NV) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|X4 Pharmaceuticals, Inc. - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACET (Adicet Bio)|CELU: PEG multiplikatori|INmune Bio Corporation (INMB) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Barinthus Biotherapeutics|KZR: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati SAB Biotherapeutics, Inc. (SABS)|Narx-foyda va o‘sish multiplikatori Akari Therapeutics PLC AKTX|PEG multiplikatori ENLV (Enlivex Therapeutics Ltd.)|PEG multiplikatori Q32 Bio Inc QTTB|GOVX: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti EDSA (edesabiotech.com)|IBIO: PEG multiplikatori|CARM - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati XTL Biopharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori Bolt Bio (BOLT)|Narxning foydaga va o‘sish sur’atiga nisbati HCW Biologics Inc. (HCWB)|Narx-foyda va o‘sish multiplikatori aptevotherapeutics.com APVO|AIM ImmunoTech - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori Aditxt Inc. ADTX|GRI - Narxning foydaga va o‘sish sur’atiga nisbati|XRTX (XORTX Corp) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|HIND: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda revbiosciences.com (REVB)|INDP (Indaptus Therapeutics, Inc.) - PEG multiplikatori|Scinai Immunotherapeutics Ltd (SCNI) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati CalciMedica, Inc. (CALI)|Narx-foyda va o‘sish multiplikatori affimed.com AFMD|Narxning foydaga va o‘sish sur’atiga nisbati Allakos ALLK|HOOK - Narx-foyda va o‘sish multiplikatori|IGMS: Narx-foyda va o‘sish multiplikatori|ITOS - PEG multiplikatori|Ocean Bio (OCEA) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti TCBP|Narxning foydaga va o‘sish sur’atiga nisbati Third Harmonic Bio
